The pharmaceutical industry rose to the challenge of Covid-19. But it has largely failed to address the threat posed by antibiotic resistance, which also kills millions. A pioneering subscription-style payment mechanism, announced by the UK last week, could provide new incentives for developers while curbing overuse.
制药业成功应对了新冠病毒的挑战。但它在很大程度上未能解决抗生素耐药性带来的威胁，后者也会导致大量死亡。英国上周宣布的一种开创性的订购式支付机制，可能为制药公司提供新的激励，同时抑制过度使用。
您已阅读13%（414字），剩余87%（2675字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。